While SLC45A3′s function in PAH is not yet elucidated, KCNK3 inhibitions leads to increased proliferation, inflammation and subsequent vasoconstriction of the pulmonary artery [183]. This evidence concerns the gene KCNK3 and pulmonary arterial hypertension.